GNRH1 and cancer: For example, MAP2K6 is elevated in focal adhesion, adhesion, long-term potentiation, vascular smooth muscle contraction, GnRH signaling pathway, pathways in cancer, but its expression decreased in Parkinson disease, oxidative phosphorylation, phenylalanine metabolism.